NCT01870596 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01870596
Title	Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	National Cancer Institute (NCI)
Indications	acute myeloid leukemia
Therapies	Cytarabine MK-8776
Age Groups:	adult \| child
Covered Countries	USA

Filter rows:

Showing 1 to 5 of 5 entries

Facility	City	State	Zip	Country	Details
Blood and Marrow Transplant Group of Georgia	Atlanta	Georgia	30342	United States	Details
Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center	Baltimore	Maryland	21287	United States	Details
Mayo Clinic	Rochester	Minnesota	55905	United States	Details
Mayo Clinic in Arizona	Scottsdale	Arizona	85259	United States	Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital	Baltimore	Maryland	21231	United States	Details

Showing 1 to 5 of 5 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01870596Clinical Trial Detail